Maynard Um
-
-
-
-
-
-
-
Jefferies on Inovio Pharmaceuticals (INO): 'Our near-term focus is on Type B outcome expected in ~50 days + ~30 days meeting minutes'
-
-
-
-
-
-
-
Inovio Pharmaceuticals (INO) On Track for PDUFA Approval in <60 Days - Citizens
-
-
-
-
-
-
-
Piper Sandler Starts Inovio Pharmaceuticals (INO) at Overweight
-
-
-
-
-
-
-
Inovio Pharma (INO) Misses Q4 EPS by 65c
-
-
-
-
-
-
-
Inovio Pharmaceuticals (INO) PT Lowered to $15 at Oppenheimer
-
-
-
-
-
-
-
Inovio Pharma (INO) Misses Q2 EPS by 119c
-
-
-
416,515 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

